Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder

Journal of Affective Disorders

Volumn 80, Issue 1, 2004, Pages 75-78

  Berger, Peter ^a   Sachs, Gabriele ^a   Amering, Michaela ^a   Holzinger, Anita ^a   Bankier, Bettina ^a   Katschnig, Heinz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Panic disorder; Personality disorder; Social phobia; Treatment outcome

Indexed keywords

PAROXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG RESPONSE; FEMALE; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PANIC; PERSONALITY DISORDER; PREDICTION; PRIORITY JOURNAL; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; MALE; PANIC DISORDER; PAROXETINE; PERSONALITY DISORDERS; PHOBIC DISORDERS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 1942535011     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(03)00043-0     Document Type: Article

References (19)

1. Amering M., Katschnig H., Berger P., Windhaber J., Baischer W., Dantendorfer K. Embarrassment about the first panic attack predicts agoraphobia in panic disorder. Behav. Res. Ther. 35:1997;517-521.
2. Basoglu M., Marks I.M., Swinson R.P., Noshirvani H., O'Sullivan G., Kuch K. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J. Affect. Disord. 30:1994;123-132.
3. de Beurs E., Lange A., van Dyck R., Koele P. Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Aust. N.Z. J. Psychiatry. 29:1995;104-113.
4. Dreessen L., Arntz A. The impact of personality disorders on treatment outcome of anxiety disorders: best-evidence synthesis. Behav. Res. Ther. 36:1998;483-504.
5. Guy W. ECDEU Assessment Manual For Psychopharmacology. 1976;U.S. Government Printing Office, Washington, DC.
6. Katschnig H., Berger P., Sachs G., Holzinger A., Amering M., Mayerhofer D., Baischer W., Windhaber J., Dantendorfer K. Gruppenpsychotherapie bei Panikstörung. Ein Slow-Open-Konzept mit kognitiven und interpersonellen Elementen. Mundt C., Linden M., Barnett W. 1997;143-146 Gruppenpsychotherapie in der Psychiatrie, Springer, Wien, New York.
7. Keller M.B., Yonkers K.A., Warshaw M.G., Pratt L.A., Gollan J.K., Massion A.O., White K., Swartz A.R., Reich J., Lavori P.W. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J. Nerv. Ment. Dis. 182:1994;290-296.
8. Klerman G.L., Weissman M.M., Rounsaville B.J., Chevron E.S. Interpersonal Psychotherapy of Depression. 1984;Basic Books, New York.
9. Lecrubier Y., Judge R. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative paroxetine panic study investigators. Acta Psychiatr. Scand. 95:1997;153-160.
10. Loranger A.W., Sartorius N., Andreoli A., Berger P., Buchheim P., Channabasavanna S.M., Coid B., Dahl A., Diekstra R.F., Ferguson B., Jacobsberg L.B., Mombour W., Pull Ch., Ono Y., Regiec D.A. The international personality disorder examination. The World Health Organization/alcohol, drug abuse, and mental health administration international pilot study of personality disorders. Arch. Gen. Psychiatry. 51:1994;215-224.
11. Margraf J., Schneider S. Panik, Angstanfälle und ihre Behandlung. 1990;Springer, Berlin, Heidelberg, New York.
12. Massion A.O., Dyck I.R., Shea M.T., Phillips K.A., Warshaw M.G., Keller M.B. Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Arch. Gen. Psychiatry. 59:2002;434-440.
13. Noyes R. Jr., Anderson D.J., Clancy J., Crowe R.R., Slymen D.J., Ghoneim M.M., Hinrichs J.V. Diazepam and propranolol in panic disorder and agoraphobia. Arch. Gen. Psychiatry. 41:1984;287-292.
14. Pollack M.H., Otto M.W., Sachs G.S., Leon A., Shear M.K., Deltito J.A., Keller M.B., Rosenbaum J.F. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J. Affect. Disord. 30:1994;273-281.
15. Rosenberg R., Bech P., Mellergard M., Ottosson J.O. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response. Acta Psychiatr. Scand. (Suppl.). 365:1991;46-52.
16. Sheehan D.V. The Anxiety Disease. 1983;Scribner, New York.
17. Slaap B.R., Van V.I., Westenberg H.G., Den Boer J. Phobic symptoms as predictors of non-response to drug therapy in panic disorder patients (a preliminary report). J. Affect. Disord. 33:1995;31-38.
18. Spitzer, R.L., National Institute of Mental Health (U.S.), 1990. User's Guide for the Structured Clinical Interview for DSM-III-R: SCID. American Psychiatric Press, Washington, DC.
19. Woodman C.L., Noyes R. Jr., Ballenger J.C., Lydiard R.B., Sievers G., Mihalko D. Predictors of response to alprazolam and placebo in patients with panic disorder. J. Affect. Disord. 30:1994;5-13.